METHODS: The ReFiND guideline will be developed in six stages. Stage one: a guideline development group has been formed to oversee the guideline methodology. Stage two: a scoping review will be conducted to identify and summarize existing guidance documents on the fidelity of non-drug, non-surgical interventions. Stage three: a Delphi study will be conducted to reach consensus on reporting items. Stage four: a consensus meeting will be held to consolidate the reporting items and discuss the wording and structure of the guideline. Stage five: a guidance statement, an elaboration and explanation document, and a reporting checklist will be developed. Stage six: different strategies will be used to disseminate and implement the ReFiND guideline.
CONCLUSIONS: The ReFiND guideline will provide a set of items developed through international consensus to improve the reporting of intervention fidelity in trials of non-drug, non-surgical interventions. This reporting guideline will enhance transparency and reproducibility in future non-drug, non-surgical intervention research.
方法:ReFiND指南将分六个阶段制定。第一阶段:成立了一个指南开发小组来监督指南方法。第二阶段:将进行范围界定审查,以确定和总结关于非药物保真度的现有指导文件,非手术干预。第三阶段:将进行Delphi研究,以就报告项目达成共识。第四阶段:将举行一次协商一致会议,以合并报告项目并讨论准则的措词和结构。第五阶段:指导声明,详细阐述和说明文件,并将制定一份报告清单。第六阶段:将使用不同的策略来传播和实施ReFIND指南。
结论:ReFiND指南将提供一系列通过国际共识制定的项目,以改善非药物试验中干预措施的报告保真度,非手术干预。该报告指南将提高未来非药物的透明度和可重复性,非手术干预研究。